United Therapeutics shares have sunk to $308.27, producing a disappointing 14% loss - worse than the S&P 500’s 1.4% drop.

United Therapeutics has high revenue growth and low debt. Read why UTHR stock is undervalued with solid financial metrics and ...

United Therapeutics Corporation (NASDAQ ... and collaborates with other companies on various drug development projects. It is also one of the 10 best healthcare stocks for long-term investment.

We expect an in-line return from the stock in the next few months. United Therapeutics is part of the Zacks Medical - Drugs industry. Over the past month, Zoetis (ZTS), a stock from the same ...

It's early days for xenotransplantation, but eGenesis, Eledon, United Therapeutics and more are working to develop solutions ...